USPTO serial 97507248
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $250
Palo Alto, CA
Palo Alto, CA
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Omar M. Wadhwa
Omar M. Wadhwa CESARI AND MCKENNA, LLPONE LIBERTY SQUAREBOSTON, MA 02109United States| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for operating and managing clinical trials by third parties; downloadable software for providing telemedicine services; downloadable software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Downloadable software for allowing clinical trial participants to provide electronic consent and withdrawn electronic consent | ACTIVE | — |
| 042 | Software as a service (SaaS) services featuring software for operating and managing clinical trials by third parties; software as a service (SaaS) services featuring software for providing telemedicine services; software as a service (SaaS) services featuring software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SaaS) services featuring software for allowing clinical trial participants to provide electronic consent and withdraw electronic consent; computer software platform as a service (PaaS) featuring computer software platforms for operating and managing clinical trials by third parties; computer software platform as a service (PaaS) featuring computer software platforms for providing telemedicine services; computer software platform as a service (PaaS) featuring computer software platforms for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer software platform as a service (PaaS) featuring computer software platforms for allowing clinical trial participants to provide electronic consent and withdraw electronic consent | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Nov 25, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 30, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 30, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 30, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 27, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 27, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 27, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 31, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 30, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 30, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 30, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 30, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 29, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 29, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 29, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 30, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 16, 2023 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jan 5, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 6, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 6, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 31, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 31, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2022 | NWAP | NEW APPLICATION ENTERED | — |